Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Plos One|February 23, 2026
A dynamic model of COVID-19 infection quantifies the impact of preventive interventions on the infection of severely immunocompromised subjects in the United KingdomCarmen Pin, Sylvia Taylor, Catia Ferreira, et al.
Cancers|August 7, 2021
A Spatial Quantitative Systems Pharmacology Platform spQSP-IO for Simulations of Tumor-Immune Interactions and Effects of Checkpoint Inhibitor ImmunotherapyChang Gong, Alvaro Ruiz-Martinez, Holly Kimko, et al.
Clinical and Translational Science|August 21, 2024
Predicting progression-free survival from measurable residual disease in chronic lymphocytic leukemiaFlorencia A Tettamanti, Holly Kimko, Shringi Sharma, et al.
Expert Opinion on Drug Delivery|June 30, 2026
Drug penetration in solid tumors: influence of drug size and capillary architectureHooman Salavati, Massimo Lai, Cesar Pichardo-Almarza, et al.
Journal of Pharmacokinetics and Pharmacodynamics|June 1, 2011
Impact of low percentage of data below the quantification limit on parameter estimates of pharmacokinetic modelsXu Steven Xu, Adrian Dunne, Holly Kimko, et al.
Cancers|June 22, 2023
Quantifying Intratumoral Heterogeneity and Immunoarchitecture Generated In-Silico by a Spatial Quantitative Systems Pharmacology ModelMehdi Nikfar, Haoyang Mi, Chang Gong, et al.
Journal of Clinical Pharmacology|February 3, 2015
Helicobacter pylori treatment in children: defining a dose for rabeprazole as a part of a triple therapy regimenHolly Kimko, An Thyssen, Diane R Mould, et al.
Clinical Pharmacokinetics|October 31, 2021
Population Pharmacokinetic Modeling of Inebilizumab in Subjects with Neuromyelitis Optica Spectrum Disorders, Systemic Sclerosis, or Relapsing Multiple SclerosisLi Yan, Holly Kimko, Bing Wang, et al.
Antimicrobial Agents and Chemotherapy|December 17, 2008
Population pharmacokinetic analysis of ceftobiprole for treatment of complicated skin and skin structure infectionsHolly Kimko, Bindu Murthy, Xu Xu, et al.
Journal of Biopharmaceutical Statistics|March 18, 2017
Use of statistical and pharmacokinetic-pharmacodynamic modeling and simulation to improve decision-making: A section summary report of the trends and innovations in clinical trial statistics conferenceHolly Kimko, Seth Berry, Michael O'Kelly, et al.
Pageof 4